Impact of Oral Osteoarthritis Therapy usage Among Other Risk Factors on Knee Replacement: a Nested Case-control Study Using the Osteoarthritis Initiative Cohort

Overview

Journal Arthritis Res Ther

Publisher Biomed Central

Specialty Rheumatology

Date 2018 Aug 9

PMID 30086786

Citations 8

Authors

Marc Dorais

Johanne Martel-Pelletier

Jean-Pierre Raynauld

Philippe Delorme

Jean-Pierre Pelletier

Affiliations

Soon will be listed here.

Abstract

Background: The aim of this study was to measure the association between exposure to commonly used oral osteoarthritis (OA) therapies and relevant confounding risk factors on the occurrence of knee replacement (KR), using the Osteoarthritis Initiative (OAI) database.

Methods: In this nested case-control design study, participants who had a KR after cohort entry were defined as "cases" and were matched with up to four controls for age, gender, income, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain, Kellgren-Lawrence grade, and duration of follow up. Exposure to oral OA therapies (acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDs), cyclooxygenase-2 (COX-2) inhibitors, narcotics, and glucosamine/chondroitin sulfate) was determined within the 3 years prior to the date of the KR. Conditional regression analyses were performed to estimate the association between KR and exposure to oral OA therapies and other potential confounding risk factors.

Results: A total of 218 participants who underwent a KR (cases) were matched to 540 controls. The median time to KR was 4.3 years among cases. The majority in both groups were Caucasian with mean age of 69 years and 61% were female. Numerically, cases were more exposed to acetaminophen, NSAIDs, and COX-2 inhibitors. Exposure to narcotics and glucosamine/chondroitin sulfate was relatively similar between cases and controls. No significant association was found between the occurrence of KR and exposure to any of the oral OA therapies within the 3 years prior to KR. A significantly higher occurrence of KR was found in Caucasian subjects (OR 1.84; 95% CI, 1.13-2.99; p = 0.015) and subjects with body mass index (BMI) ≥ 27 kg/m (OR 1.65; 95% CI, 1.06-2.58; p = 0.027).

Conclusion: This study provides evidence that the main risk factors leading to KR are disease severity, symptoms and high BMI. Importantly, exposure to oral OA therapies was not associated with the occurrence of KR.

Citing Articles

Association between Metformin Use and Risk of Total Knee Arthroplasty and Degree of Knee Pain in Knee Osteoarthritis Patients with Diabetes and/or Obesity: A Retrospective Study.

Chen S, Ruan G, Zeng M, Chen T, Cao P, Zhang Y J Clin Med. 2022; 11(16).

PMID: 36013035 PMC: 9409735. DOI: 10.3390/jcm11164796.

Mycelium Ameliorates In Vivo Progression of Osteoarthritis.

Yang S, Fang C, Chen Y, Chen W, Lee L, Chen C Nutrients. 2022; 14(13).

PMID: 35807786 PMC: 9268003. DOI: 10.3390/nu14132605.

Effects of medications on incidence and risk of knee and hip joint replacement in patients with osteoarthritis: a systematic review and meta-analysis.

Cui B, Chen Y, Tian Y, Liu H, Huang Y, Yin G Adv Rheumatol. 2022; 62(1):22.

PMID: 35761320 DOI: 10.1186/s42358-022-00253-4.

Risk factors associated with the occurrence of total knee arthroplasty in patients with knee osteoarthritis: a nested case-control study.

Pelletier J, Dorais M, Paiement P, Raynauld J, Martel-Pelletier J Ther Adv Musculoskelet Dis. 2022; 14:1759720X221091359.

PMID: 35510169 PMC: 9058358. DOI: 10.1177/1759720X221091359.

Nesfatin-1 facilitates IL-1β production in osteoarthritis synovial fibroblasts by suppressing miR-204-5p synthesis through the AP-1 and NF-κB pathways.

Lee K, Chen B, Liu S, Lin Y, Tsai C, Ko C Aging (Albany NY). 2021; 13(18):22490-22501.

PMID: 34560673 PMC: 8507299. DOI: 10.18632/aging.203559.

References

Berthiaume M, Raynauld J, Martel-Pelletier J, Labonte F, Beaudoin G, Bloch D . Meniscal tear and extrusion are strongly associated with progression of symptomatic knee osteoarthritis as assessed by quantitative magnetic resonance imaging. Ann Rheum Dis. 2004; 64(4):556-63. PMC: 1755443. DOI: 10.1136/ard.2004.023796. View

Dodin P, Pelletier J, Martel-Pelletier J, Abram F . Automatic human knee cartilage segmentation from 3D magnetic resonance images. IEEE Trans Biomed Eng. 2010; 57(11). DOI: 10.1109/TBME.2010.2058112. View

Raynauld J, Martel-Pelletier J, Haraoui B, Choquette D, Dorais M, Wildi L . Risk factors predictive of joint replacement in a 2-year multicentre clinical trial in knee osteoarthritis using MRI: results from over 6 years of observation. Ann Rheum Dis. 2011; 70(8):1382-8. DOI: 10.1136/ard.2010.146407. View

Martel-Pelletier J, Roubille C, Abram F, Hochberg M, Dorais M, Delorme P . First-line analysis of the effects of treatment on progression of structural changes in knee osteoarthritis over 24 months: data from the osteoarthritis initiative progression cohort. Ann Rheum Dis. 2013; 74(3):547-56. DOI: 10.1136/annrheumdis-2013-203906. View

Roubille C, Martel-Pelletier J, Abram F, Dorais M, Delorme P, Raynauld J . Impact of disease treatments on the progression of knee osteoarthritis structural changes related to meniscal extrusion: Data from the OAI progression cohort. Semin Arthritis Rheum. 2015; 45(3):257-67. DOI: 10.1016/j.semarthrit.2015.05.001. View

Huskisson E, Berry H, Gishen P, Jubb R, Whitehead J . Effects of antiinflammatory drugs on the progression of osteoarthritis of the knee. LINK Study Group. Longitudinal Investigation of Nonsteroidal Antiinflammatory Drugs in Knee Osteoarthritis. J Rheumatol. 1995; 22(10):1941-6. View

Pelletier J, Cooper C, Peterfy C, Reginster J, Brandi M, Bruyere O . What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis?. Ann Rheum Dis. 2013; 72(10):1594-604. DOI: 10.1136/annrheumdis-2013-203631. View

Klop C, de Vries F, Lalmohamed A, Mastbergen S, Leufkens H, Noort-van der Laan W . COX-2-selective NSAIDs and risk of hip or knee replacements: a population-based case-control study. Calcif Tissue Int. 2012; 91(6):387-94. DOI: 10.1007/s00223-012-9646-x. View

Lapane K, Yang S, Driban J, Liu S, Dube C, McAlindon T . Effects of prescription nonsteroidal antiinflammatory drugs on symptoms and disease progression among patients with knee osteoarthritis. Arthritis Rheumatol. 2014; 67(3):724-32. PMC: 4342290. DOI: 10.1002/art.38933. View

10.

Breslow N, Day N . Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. IARC Sci Publ. 1987; (82):1-406. View

11.

Raynauld J, Martel-Pelletier J, Bias P, Laufer S, Haraoui B, Choquette D . Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI. Ann Rheum Dis. 2008; 68(6):938-47. DOI: 10.1136/ard.2008.088732. View

12.

Roos E, Roos H, Lohmander L, Ekdahl C, Beynnon B . Knee Injury and Osteoarthritis Outcome Score (KOOS)--development of a self-administered outcome measure. J Orthop Sports Phys Ther. 1998; 28(2):88-96. DOI: 10.2519/jospt.1998.28.2.88. View

13.

Cicuttini F, Jones G, Forbes A, Wluka A . Rate of cartilage loss at two years predicts subsequent total knee arthroplasty: a prospective study. Ann Rheum Dis. 2004; 63(9):1124-7. PMC: 1755122. DOI: 10.1136/ard.2004.021253. View

14.

Solomon D, Rassen J, Glynn R, Lee J, Levin R, Schneeweiss S . The comparative safety of analgesics in older adults with arthritis. Arch Intern Med. 2010; 170(22):1968-76. DOI: 10.1001/archinternmed.2010.391. View

15.

Raynauld J, Martel-Pelletier J, Beaulieu A, Bessette L, Morin F, Choquette D . An open-label pilot study evaluating by magnetic resonance imaging the potential for a disease-modifying effect of celecoxib compared to a modelized historical control cohort in the treatment of knee osteoarthritis. Semin Arthritis Rheum. 2010; 40(3):185-92. DOI: 10.1016/j.semarthrit.2009.10.003. View

16.

Eckstein F, Kwoh C, Boudreau R, Wang Z, Hannon M, Cotofana S . Quantitative MRI measures of cartilage predict knee replacement: a case-control study from the Osteoarthritis Initiative. Ann Rheum Dis. 2012; 72(5):707-14. DOI: 10.1136/annrheumdis-2011-201164. View

17.

Reijman M, Bierma-Zeinstra S, Pols H, Koes B, Stricker B, Hazes J . Is there an association between the use of different types of nonsteroidal antiinflammatory drugs and radiologic progression of osteoarthritis? The Rotterdam Study. Arthritis Rheum. 2005; 52(10):3137-42. DOI: 10.1002/art.21357. View

18.

Hafezi-Nejad N, Guermazi A, Roemer F, Eng J, Zikria B, Demehri S . Long term use of analgesics and risk of osteoarthritis progressions and knee replacement: propensity score matched cohort analysis of data from the Osteoarthritis Initiative. Osteoarthritis Cartilage. 2015; 24(4):597-604. DOI: 10.1016/j.joca.2015.11.003. View

19.

Riddle D, Kong X, Jiranek W . Two-year incidence and predictors of future knee arthroplasty in persons with symptomatic knee osteoarthritis: preliminary analysis of longitudinal data from the osteoarthritis initiative. Knee. 2009; 16(6):494-500. PMC: 2801437. DOI: 10.1016/j.knee.2009.04.002. View

20.

Raynauld J, Pelletier J, Abram F, Dodin P, Delorme P, Martel-Pelletier J . Long-Term Effects of Glucosamine and Chondroitin Sulfate on the Progression of Structural Changes in Knee Osteoarthritis: Six-Year Followup Data From the Osteoarthritis Initiative. Arthritis Care Res (Hoboken). 2016; 68(10):1560-6. DOI: 10.1002/acr.22866. View